[Minimal change disease and focal segmental glomerulosclerosis]

Area of Science:

• Nephrology
• Pathology

Background:

• Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are primary causes of nephrotic syndrome in pediatric and young adult populations.
• These conditions share a common pathophysiology involving glomerular podocytes and their cytoskeletal structure, leading to the classification as
• podocytopathies

Purpose of the Study:

• To compare the similarities and differences between MCD and FSGS.
• To summarize recent findings on the pathophysiology and treatment of these glomerular diseases.

Main Methods:

• Review of clinical courses for disease discrimination.
• Electron microscopy of renal biopsies in adults for definitive diagnosis.
• Analysis of current treatment strategies and sparse clinical data.

Main Results:

• In adults, distinguishing MCD from FSGS and other diagnoses necessitates renal biopsy with electron microscopy.
• Clinical course is crucial for identifying primary versus secondary disease forms.
• Treatment remains largely empirical, relying on high-dose steroids and immunosuppressants, with a focus on addressing underlying conditions in secondary cases.

Conclusions:

• MCD and FSGS represent distinct podocytopathies with overlapping yet differentiating clinical and pathological features.
• Accurate diagnosis, particularly in adults, relies on advanced techniques like electron microscopy.
• Further research is needed to optimize treatment protocols for these challenging nephrotic syndromes.